Okey Stephanie Insider Trades

Insider Trading History

Track insider trading activity for Okey Stephanie. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $252k 7,008 shares
Last Trade
Jun 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$246k 6,900 shares
$35.67
$35.91
PTC Therapeutics
PTC Therapeutics PTCT
Director
Holding Value $1.81M 22,000 shares
Last Trade
Mar 10, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.04M 15,167 shares
$68.56
$82.13
PTC Therapeutics
PTC Therapeutics PTCT
Director
Holding Value $0 0 shares
Last Trade
Mar 10, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$960k 14,000 shares
$68.56
$82.13
PTC Therapeutics
PTC Therapeutics PTCT
Director
Holding Value $657k 8,000 shares
Last Trade
Mar 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$980k 14,000 shares
$70.00
$82.13
PTC Therapeutics
PTC Therapeutics PTCT
Director
Holding Value $657k 8,000 shares
Last Trade
Mar 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$401k 6,333 shares
$63.38
$82.13
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $478k 13,300 shares
Last Trade
Mar 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$119k 3,000 shares
$39.67
$35.91
PTC Therapeutics
PTC Therapeutics PTCT
Director
Holding Value $986k 12,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$574k 7,475 shares
$76.74
$82.13
PTC Therapeutics
PTC Therapeutics PTCT
Director
Holding Value $657k 8,000 shares
Last Trade
Nov 20, 2025 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$66.3k 867 shares
$76.46
$82.13
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $585k 16,300 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$335k 10,350 shares
$32.33
$35.91
PTC Therapeutics
PTC Therapeutics PTCT
Director
Holding Value $728k 8,867 shares
Last Trade
Mar 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$270k 5,000 shares
$54.00
$82.13
PTC Therapeutics
PTC Therapeutics PTCT
Director
Holding Value $1.14M 13,867 shares
Last Trade
Jan 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$410k 8,800 shares
$46.54
$82.13
Catalent
Catalent CTLT
Director
Holding Value $0 0 shares
Last Trade
Dec 18, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$802k 12,635 shares
$63.48
$63.48
Catalent
Catalent CTLT
Director
Holding Value $802k 12,635 shares
Last Trade
Oct 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$275k 4,663 shares
$58.97
$63.48
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $449k 12,500 shares
Last Trade
Jun 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$559k 12,500 shares
$44.71
$35.91
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $844k 23,500 shares
Last Trade
Mar 28, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$819k 17,500 shares
$46.81
$35.91
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $215k 6,000 shares
Last Trade
Mar 28, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$812k 17,500 shares
$46.38
$35.91
PTC Therapeutics
PTC Therapeutics PTCT
Director
Holding Value $821k 10,000 shares
Last Trade
Feb 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$257k 10,000 shares
$25.69
$82.13
Catalent
Catalent CTLT
Director
Holding Value $506k 7,972 shares
Last Trade
Oct 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$275k 6,993 shares
$39.32
$63.48
Catalent
Catalent CTLT
Director
Holding Value $62.1k 979 shares
Last Trade
Aug 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.7k 979 shares
$45.64
$63.48
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $628k 17,500 shares
Last Trade
Jun 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$356k 17,500 shares
$20.32
$35.91

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up